Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Part of paid clinical trials in New York, New York.

Sponsor
The Rogosin Institute
Study ID
NCT01802034
Status
Recruiting
Apply to this trial

Conditions

  • Diabetic Nephropathy
  • Glomerulonephritis, IGA
  • Kidney Diseases
  • Kidney Failure, Chronic
  • Lupus Nephritis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to store biospecimens and electronic data in control subjects without established renal disease. This initiative will provide an opportunity to compare data from various disease states and controls with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating noninvasive clinical and biological features that predict renal biopsy findings.

Key Dates

Start date
Feb 28, 2013
Status verified
Apr 2025
Primary completion
Aug 31, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Native, Renal Tissue Preservation Group
    Subjects who have a renal biopsy and the tissue is possessed and maintained by the RENAL AID repository.
  • Arm: Native, Non-tissue Preservation Group
    1. Subjects who have had a renal biopsy but the tissue is not held by RENAL AID repository; and/or 2. Subjects with diabetes and renal disease who have not had a renal biopsy.
  • Arm: Transplant Nephropathy Group
    Subjects who have had a renal transplant and require a transplant biopsy for either surveillance or "for-cause" indications.

Primary Outcome Measure

Change in disease progression [ Time Frame: Up to 10 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The Rogosin InstituteNew YorkNew York10021
Betty-Jane Sloan, M.A.
[email protected]
646-317-0701
Alan S Perlman, MD (PRINCIPAL_INVESTIGATOR)
Nathaniel Berman, MD (SUB_INVESTIGATOR)
James M Chevalier, MD (SUB_INVESTIGATOR)
Choli Hartono, MD (SUB_INVESTIGATOR)
Surya V Seshan, MD (SUB_INVESTIGATOR)
Manikkam Suthanthiran, MD (SUB_INVESTIGATOR)
John CL Wang, MD (SUB_INVESTIGATOR)
Thomas S Parker, PhD (SUB_INVESTIGATOR)
Daniel M Levine, PhD (SUB_INVESTIGATOR)
David Serur, MD (SUB_INVESTIGATOR)
Jun Lee, MD (SUB_INVESTIGATOR)
Liu M Frank, MD (SUB_INVESTIGATOR)
Meredith J Aull, PharmD (SUB_INVESTIGATOR)
Nelson Chen, CRC (SUB_INVESTIGATOR)

Find similar trials in New York, NY

By condition
Lupus (SLE)
By specialty
RheumatologyAutoimmune disease
By research site
The Rogosin Institute· New York, NY

Related Studies